ProFound AI Risk
iCAD
Product specifications |
Information source:
Vendor
Last updated: May 27, 2022 |
General | |
---|---|
Product name | ProFound AI Risk |
Company | iCAD |
Subspeciality | Breast |
Modality | Mammography |
Disease targeted | Breast cancer |
Key-features | Individual 1y/2y/3y breast cancer risk score |
Suggested use | During: report suggestion |
Data characteristics | |
Population | Asymptomatic screening population |
Input | 2D Mammography, 3D Digital Breast Tomosynthesis, age of patient |
Input format | DICOM |
Output | Risk score |
Output format | DICOM SR, GSPS |
Technology | |
Integration | Integration in standard reading environment (PACS), Stand-alone third party application |
Deployment | Locally on dedicated hardware |
Trigger for analysis | Automatically, right after the image acquisition |
Processing time | 1 - 10 minutes |
Certification | |
CE
|
Certified,
Class I
, MDD
|
FDA
|
No or not yet |
Market presence | |
On market since | 07-2020 |
Distribution channels | iCAD inc, RMS Medical Devices (Benelux), Sectra Amplifier Store |
Countries present (clinical, non-research use) | - |
Paying clinical customers (institutes) | >1 |
Research/test users (institutes) | >1 |
Pricing | |
Pricing model | |
Based on | |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |